2BBBullish & Bearish
Health Care

EyePoint, Inc. (EYPT) Stock Score & Signals

EyePoint, Inc. (EYPT) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 13 out of 100.

About EyePoint, Inc.

EyePoint (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to improve the lives of people with serious retinal diseases.

2BB score and signals

EyePoint, Inc.’s current 2BB score is 13 out of 100, built from the signal categories below.

SignalScoreReading
Activity5Very Low
Momentum50Stable
Financial strength0Very Weak
Company Presence48Normal
Risk46Moderate (provisional)

Company facts

HeadquartersWatertown, Massachusetts, United States
Founded2000
Employees214
52-week range$2.93 – $19.01

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-05-04—-0.6018—$130,815.00
2027-03-02—-0.7157—$299,094.00
2026-11-12—-0.9492—$227,541.00
2026-08-05—-0.9705—$414,997.00